Caricamento...
The minimum dose of dexmedetomidine required for cessation of postspinal anesthesia shivering: A prospective observational study
BACKGROUND AND AIMS: Shivering is a common postanesthesia adverse event with multiple etiologies. Dexmedetomidine, a centrally acting alpha-2 adrenergic agonist, is known to reduce the shivering threshold. However, the minimum dose at which dexmedetomidine causes cessation of shivering is unknown. T...
Salvato in:
| Pubblicato in: | J Anaesthesiol Clin Pharmacol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Medknow Publications & Media Pvt Ltd
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5791263/ https://ncbi.nlm.nih.gov/pubmed/29416242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/joacp.JOACP_115_16 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|